abstract |
The invention relates to a method of screening for a compound able to modulate the activity of an N-type voltage-dependent calcium channel consisting of the Cav2.2 (α1B), α2δ1, ß1 and Ϝ4 subunits; wherein said compound may be in one embodiment e.g. an antibody or an antisense nucleotide sequence. |